Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3363020 | 0.80 | POLB (0.41) | KMT2AALDH1A1LMNAMEN1OPRM1 | |
| SCHEMBL4805192 | 0.77 | TSHR (0.45) | KMT2AALDH1A1LMNAMEN1OPRM1 | |
| SCHEMBL4886714 | 0.75 | PABPC1 (0.41) | KMT2AALDH1A1LMNAMEN1TSHR | |
| SCHEMBL410270 | 0.75 | ADRB2 (0.45) | KMT2AALDH1A1LMNAMEN1TSHR | |
| SCHEMBL682099 | 0.74 | CYP2D6 (0.36) | KMT2AALDH1A1LMNAMEN1OPRM1 | |
| SCHEMBL410781 | 0.73 | ALDH1A1 (0.44) | KMT2AALDH1A1LMNASLC6A3SLC6A2 | |
| SCHEMBL15501122 | 0.72 | GSR (0.40) | KMT2AOPRM1OPRL1SLC6A3SLC6A2 | |
| SCHEMBL681183 | 0.72 | GSR (0.40) | KMT2AOPRM1OPRL1SLC6A3SLC6A2 | |
| SCHEMBL28343381 | 0.72 | PABPC1 (0.35) | KMT2AALDH1A1LMNAMEN1OPRM1 | |
| SCHEMBL5935976 | 0.72 | TSHR (0.37) | KMT2AALDH1A1LMNAMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1284966-B1 | PROCESS FOR THE SYNTHESIS OF AMINE ETHERS FROM SECONDARY AMINO OXIDES | BASF SE (DE) | 2010-03-17 | — | — | EP | disclosed |
| US-7402675-B2 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-07-22 | — | — | US | disclosed |
| US-6900328-B2 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-05-31 | — | — | US | disclosed |
| US-20050043552-A1 | Process for the synthesis of amine ethers from secondary amino oxides | HAFNER ANDREAS (CH) | 2005-02-24 | — | — | US | disclosed |
| US-20030171461-A1 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORP. | 2003-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043552-A1 | Process for the synthesis of amine ethers from secondary amino oxides | CYC1, AOC2, CBR1 | KMT2A 1447/4885ALDH1A1 958/4885LMNA 3207/4885 |
| US-20030171461-A1 | Process for the synthesis of amine ethers from secondary amino oxides | IL4I1, HCCS, CBR1 | KMT2A 1055/4885ALDH1A1 2416/4885LMNA 756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.